Table 3.
Spot | Protein ID | Accession # | Fold | Possible functions |
---|---|---|---|---|
213 |
Actin-related protein 3c |
NP-001157930 |
+2.8 |
ATP binding |
457 |
Annexin A5 |
NP-001145 |
+3.6 |
Signal/inflammation |
604 |
Gamma-actin |
CAA27723 |
+3.5 |
ATP binding |
645 |
Rho GDP-dissociation inhibitor 2 |
NP-001166 |
+4.1 |
Metabolism |
740 |
Chain J |
ABI63362 |
+4.0 |
Antigen binding |
805 |
Protein S100-A9 |
NP-002956 |
+3.9 |
Calcium ion binding |
896 |
Protein S100-A8 |
NP-002955 |
+4.8 |
Calcium ion binding |
869 |
Peroxisome biogenesis factor13 |
NP_002609 |
+5.4 |
Redox |
601 |
Peroxiredoxin-6 |
P30041 |
+2.9 |
Antioxidant |
505 |
Leukocyte elastase inhibitor |
NP_109591 |
+4.5 |
Related to proteolysis |
540 |
Voltage-dependent anion-selective |
P21796 |
+2.6 |
Transport channel protein 1 |
61 |
Methylenetetrahydrofolate |
EAW47761 |
+3.1 |
Redox/metablism |
|
dehydrogenase (NADP + dependent) |
|
|
|
|
1-like, isoform CLCP |
|
|
|
710 |
GSTP1 |
CAG29357 |
+5.8 |
Transferase |
746 |
Interleukin-1 receptor antagonist |
CAA37386 |
+3.7 |
Acute-phase response |
|
protein |
|
|
|
764 |
Tumor necrosis factor alpha- |
NP_001161414 |
+3.2 |
Transcript protein8-induced protein 8-like protein1 |
605 |
6-phosphogluconolactonase |
NP_036220 |
+2.9 |
Hydrolase |
200 |
Aldehyde dehydrogenase |
AAA51693 |
+2.7 |
Redox |
343 |
Galectin-3 |
BAA22164 |
-2.9 |
Carbohydrate binding |
409 |
Electron transfer flavprotein |
CAB37832 |
-2.8 |
Electron carrier |
|
subunit beta |
|
|
|
882 |
Heat shock protein 27 |
AAA62175 |
-4.1 |
Inflammation/apoptosis |
148 |
Macrophage-capping protein |
AAA59570 |
-2.8 |
Actin capping |
794 |
Napsin-A |
NP_004842 |
-3.1 |
Protein proteolysis |
727 |
Superoxide dismutase |
AAB59626 |
-2.6 |
Antioxidant |
235 |
CathepsinB |
NP_680093 |
-3.1 |
Peptide binding |
650 |
Tripeptidyl-peptidase I |
O14773 |
-2.8 |
Aminopeptodrate |
432 |
Annexin A8 |
AAH73755 |
-3.5 |
Calcium ion binding |
201 | Protein disulfide isomerase-related | AAB50217 | -2.9 | Redox regulation protein 5 |
+: Increased fold in the recovery phase; -: Increased fold in the exudative phase.